Incivek for hepatitis C infection is approved in US
The U.S. Food and Drug Administration (FDA) approves Incivek for hepatitis C – The U.S. Food and Drug Administration approved Incivek (telaprevir) to treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies.